Treatment of Atopic Dermatitis on the Scalp
Medium-potency topical corticosteroids are the first-line treatment for atopic dermatitis on the scalp, applied once daily for 2-4 weeks, followed by topical calcineurin inhibitors for maintenance therapy. 1
First-Line Treatment
Initial therapy: Medium-potency topical corticosteroids
Application schedule for moderate-severe cases:
- Initial phase: Once daily for 4 weeks
- Tapering phase: Alternate days for 4 weeks
- Maintenance phase: Twice weekly for 4 weeks before reassessment 1
Maintenance Therapy
Topical calcineurin inhibitors (tacrolimus or pimecrolimus) are recommended for maintenance after disease stabilization 3, 1
- Apply 2-3 times per week to previously affected areas 3
- These agents do not cause skin atrophy, making them safer for long-term use 2
- Tacrolimus 0.03% is approved for children ≥2 years old 1
- Pimecrolimus 1% cream is indicated as second-line therapy for mild to moderate atopic dermatitis in patients 2 years and older 4
Alternating therapy approach:
- For moderate to severe cases, consider alternating between topical corticosteroids (weekends) and tacrolimus (weekdays) to reduce corticosteroid side effects while maintaining control 1
Adjunctive Measures
Emollient therapy:
- Use fragrance-free emollients liberally and frequently (3-8 times daily)
- Apply immediately after washing to trap moisture
- Continue even when skin appears normal 1
Cleansing:
- Use soap-free cleansers for washing the scalp 5
- Avoid irritants and harsh shampoos
Infection prevention:
When to Consider Advanced Therapies
Phototherapy:
Systemic therapy:
Important Considerations
Monitoring: Watch for signs of skin atrophy, which can occur with topical corticosteroids after just 2 weeks of use 2
Efficacy comparison: Studies show that tacrolimus 0.03% applied twice daily is more effective than 1% hydrocortisone acetate for moderate to severe atopic dermatitis, with a 76.7% vs 47.6% reduction in severity scores 7
Application frequency: While twice-daily application of hydrocortisone is beneficial on the first day of treatment, once-daily application may be sufficient from the second day onward as the skin barrier begins to restore 8
Referral indications:
- Diagnostic uncertainty
- Poor response to initial treatment
- Severe or widespread disease requiring systemic therapy 1
Remember that continued use of either topical corticosteroids (1-2× per week) or topical calcineurin inhibitors (2-3× per week) after disease stabilization is recommended to reduce subsequent flares or relapses 3.